Canine ehrlichiosis is a tick-borne bacterial infection caused by Ehrlichia canis, an organism that invades a dog’s white blood cells and can trigger a cascade of problems ranging from mild fever to life-threatening blood disorders. The disease is transmitted by the brown dog tick (Rhipicephalus sanguineus), one of the most widespread tick species in warm and temperate climates worldwide. What makes ehrlichiosis especially tricky is that it progresses through distinct stages, and a dog can appear perfectly healthy for months or even years while still harboring the bacteria.
How Dogs Get Infected
A dog contracts E. canis when an infected brown dog tick attaches and begins feeding. What surprises many owners is how fast this can happen. Research has shown that the bacterium can be transmitted within just a few hours of tick attachment, far sooner than the 24-to-48-hour window often cited for other tick-borne diseases. In one study using dogs and artificial feeding systems, E. canis DNA was detected as early as three to six hours after tick attachment.1PubMed Central. Assessment of the speed of transmission of Ehrlichia canis, Anaplasma phagocytophilum, and Borrelia burgdorferi sensu stricto by infected ticks through an in vitro experimental model Another study confirmed that dogs challenged with infected ticks for only three hours still became infected, with the bacterium detected in the feeding medium as early as eight hours after tick placement.2PubMed. Transmission of Ehrlichia canis by Rhipicephalus sanguineus ticks feeding on dogs and on artificial membranes The practical upshot is that removing a tick within a few hours of attachment does not guarantee your dog is safe. This speed of transmission is one reason tick prevention products matter so much.
The Three Stages of the Disease
Ehrlichiosis in dogs unfolds in three recognized phases, and understanding them helps explain why the disease can be both sneaky and devastating.
Acute Phase
The acute phase typically begins one to three weeks after a tick bite. Dogs develop fever, lethargy, reduced appetite, and sometimes swollen lymph nodes or a discharge from the nose or eyes. Bloodwork during this stage often shows a drop in platelet counts, which are the cells responsible for clotting. Some dogs will have mild anemia as well. Many dogs in the acute phase improve on their own within a couple of weeks even without treatment, which can give owners a false sense of relief. The bacteria have not been eliminated, though. They have simply gone underground.
Subclinical Phase
This is the deceptive stage. A dog looks and acts normal, with few or no outward symptoms, yet the organism persists inside the body. Research has demonstrated that clinically healthy dogs in this phase are carriers: one study found E. canis DNA in the spleens of all carrier dogs tested, and in the bone marrow and blood of some, up to 34 months after infection.3PubMed Central. Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis The spleen appears to be the primary hideout for the bacterium and the last organ to clear it. A separate study reinforced how elusive the organism can be during this phase: over half of dogs with suspected subclinical ehrlichiosis tested negative on standard blood PCR, yet more than 60 percent turned up positive when tissue biopsies from bone marrow, liver, or spleen were tested directly.4PubMed Central. Demonstrating the presence of Ehrlichia canis DNA from different tissues of dogs with suspected subclinical ehrlichiosis A dog can stay in this subclinical limbo for months to years. Some eventually clear the infection on their own. Others progress to the chronic stage.
Chronic Phase
Chronic ehrlichiosis is where the disease becomes genuinely dangerous. Dogs may develop severe pancytopenia, meaning all major blood cell lines drop: red cells, white cells, and platelets. Symptoms can include dramatic weight loss, bleeding from the nose or gums, bruising, swelling of the limbs, and profound weakness.5The Journal of Infectious Diseases. Ehrlichiosis—A Disease of Animals and Humans Certain breeds, particularly German Shepherds, have been reported to be more susceptible to severe outcomes, though the reasons are not fully understood. Once the bone marrow has been severely suppressed, treatment becomes much harder and the prognosis worsens considerably.
What Bloodwork Reveals
A veterinarian suspecting ehrlichiosis will typically start with a complete blood count and serum chemistry panel. The hallmark finding is thrombocytopenia, a low platelet count, which shows up across all stages of the disease. In naturally infected dogs, drops in hemoglobin, red blood cell count, and packed cell volume are common and can signal underlying bleeding problems or bone marrow suppression.6PubMed Central. Hematobiochemical changes in ehrlichiosis in dogs of Anand region, Gujarat Even dogs with low-level infections show measurable changes in blood cell counts and liver enzymes.7PubMed Central. Evaluation of clinical, biochemical and haematological markers in natural infection of canine monocytic ehrlichiosis
A distinctive pattern on serum protein analysis also raises a red flag. Infected dogs tend to have low albumin and high globulin levels, particularly a spike in gamma-globulins, which are antibodies produced as the immune system tries to fight the infection.8PubMed. Serum protein alterations in canine ehrlichiosis This combination of low albumin and high globulins is unusual enough that it should prompt a veterinarian to test for ehrlichiosis. In some dogs, the globulin spike takes the form of a monoclonal gammopathy, a pattern that can mimic certain cancers like multiple myeloma and requires careful differentiation.9PubMed. Monoclonal gammopathy associated with naturally occurring canine ehrlichiosis Even in the subclinical phase, when dogs seem fine, elevated gamma-globulin concentrations can be a telltale sign that something is going on.10PubMed. Characterization of the subclinical phase of canine ehrlichiosis in experimentally infected beagle dogs
How the Diagnosis Is Confirmed
Point-of-care antibody tests, the kind your vet can run in the clinic in minutes, detect exposure to E. canis by looking for antibodies. These are useful screening tools, but they have limitations: a positive antibody test tells you the dog has been exposed, not necessarily that it currently has an active infection. And in very early infection, antibodies may not yet be detectable.
PCR testing, which looks for the bacterium’s DNA directly, is considered valuable because it confirms active infection rather than mere exposure. Compared to other methods, PCR is quick and practical for clinical use.11PubMed Central. Comparison of PCR with other tests for early diagnosis of canine ehrlichiosis However, as described earlier, a negative blood PCR does not rule out the disease if the organism is hiding in the spleen or bone marrow. In subclinical dogs, tissue biopsy PCR picks up infections that standard blood PCR misses.12PubMed Central. Demonstrating the presence of Ehrlichia canis DNA from different tissues of dogs with suspected subclinical ehrlichiosis For most clinical situations, vets combine antibody testing, PCR, and bloodwork findings to build a complete picture.
Complications Beyond the Blood
Ehrlichiosis can cause problems well beyond low blood counts. Two organ systems deserve special mention.
Eye Disease
Ocular involvement is more common than many owners realize. A retrospective study in Barcelona found that over a third of dogs diagnosed with monocytic ehrlichiosis had eye problems, and nearly two-thirds of those dogs showed eye signs as their only symptom, with no other visible illness.13PubMed. Ocular signs of canine monocytic ehrlichiosis: a retrospective study in dogs from Barcelona, Spain The most common eye problem was retinal detachment caused by fluid buildup, followed by inflammation inside the eye (uveitis) and optic nerve inflammation. About a third of affected dogs had bleeding inside the eye. All eye disease in this group was bilateral, meaning both eyes were affected. A dog that suddenly develops red, swollen, or painful eyes in a tick-endemic area should be tested for ehrlichiosis even if it seems otherwise healthy.
Nervous System Involvement
Neurological complications are less frequent but well-documented. In one case, a dog presented with inability to walk properly on all four legs, vestibular dysfunction causing head tilt and balance problems, and pain along the spine. MRI revealed multiple small bright spots scattered through the brain and cervical spinal cord, along with inflammation of the membranes surrounding the brain.14Case Reports in Veterinary Medicine. Magnetic Resonance Imaging Lesions in the Central Nervous System of a Dog with Canine Monocytic Ehrlichiosis While neurological involvement is not the norm, it illustrates how the disease can masquerade as a primary brain or spinal cord problem, leading to delayed diagnosis if tick-borne disease is not on the radar.
Kidney Damage
The immune response to E. canis can itself cause harm. The bacterium triggers a massive antibody response, and the resulting immune complexes can lodge in the kidneys, causing inflammation. Studies of naturally infected dogs have found that kidney lesions appear in virtually all cases examined, with the most common pattern being a membranoproliferative glomerulopathy, a type of damage to the filtering units of the kidney driven by immune complex deposition.15Brazilian Journal of Veterinary Pathology. Renal histopathological changes in dogs naturally infected with Ehrlichia canis This kidney damage can develop even during the subclinical phase, when the dog appears outwardly normal, which raises the concern that kidney injury may be quietly progressing long before any clinical signs appear.16PLoS ONE. Glomerulotubular pathology in dogs with subclinical ehrlichiosis Monitoring kidney values in dogs with known ehrlichiosis exposure is worthwhile even after clinical signs resolve.
Treatment and Its Limits
Doxycycline is the standard treatment. The typical protocol is a daily oral dose of around 10 mg/kg for 28 days. In a treatment trial, this regimen cleared E. canis from most dogs, though some required a second or third course before PCR results stayed negative for the following three months.17PubMed Central. The efficacy of a generic doxycycline tablet in the treatment of canine monocytic ehrlichiosis
Timing matters enormously. When doxycycline was started during the acute or subclinical phase in experimental infections, dogs’ blood became PCR-negative as they improved clinically. But when treatment did not begin until the chronic phase, blood samples remained intermittently PCR-positive even after the full course.18PubMed Central. Efficacy of a doxycycline treatment regimen initiated during three different phases of experimental ehrlichiosis That same study contained a sobering finding: ticks that fed on treated dogs still tested positive for E. canis regardless of when treatment was started. Whether this residual bacterial DNA represents viable organisms or just leftover genetic material is an open question. Very sensitive testing methods have shown that low-level E. canis DNA can persist in the blood for extended periods after treatment, and researchers are still working to determine whether this reflects true persistent infection or just dead bacterial fragments.19PubMed. Longitudinal assessment of Ehrlichia canis bacterial load in naturally infected dogs using droplet digital PCR The bottom line for owners is that early treatment gives the best chance of full clearance, and dogs treated in the chronic phase may need more aggressive or prolonged therapy.
When Ehrlichiosis Comes with Company
Because the brown dog tick can carry more than one pathogen, co-infections are a real concern. Babesia vogeli, a parasite that destroys red blood cells, shares the same tick vector. When dogs are infected with both E. canis and Babesia simultaneously, the clinical picture worsens. A study comparing dogs with Babesia alone versus co-infected dogs found that the co-infected group had significantly lower red blood cell counts, hemoglobin levels, and hematocrit values.20PubMed Central. Clinicopathological and molecular profiles of Babesia vogeli infection and Ehrlichia canis coinfection In practice, this means a dog that tests positive for ehrlichiosis and is sicker than expected should be checked for concurrent infections as well. Treatment plans may need to address multiple organisms at once.
Tick Prevention and the Vaccine Question
Given how quickly E. canis can be transmitted after a tick attaches, killing or repelling ticks before they bite is the most reliable way to prevent infection. Not all tick products are created equal in this regard. A comparative study tested three popular products against infected ticks and found that a permethrin/imidacloprid spot-on (Advantix) completely prevented transmission: none of the treated dogs became infected, compared to six out of eight untreated controls. By contrast, dogs treated with afoxolaner (NexGard) or fluralaner (Bravecto), both oral isoxazoline products, still had some infections break through, with four out of eight and two out of eight becoming infected, respectively.21PubMed Central. Comparative efficacy of oral administrated afoxolaner (NexGard™) and fluralaner (Bravecto™) with topically applied permethrin/imidacloprid (Advantix®) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs The likely reason is that permethrin acts as a repellent, keeping ticks from attaching in the first place, while oral products work by killing the tick after it bites and begins feeding. Given the three-to-six-hour transmission window, a product that prevents attachment has an advantage over one that kills the tick after it has already started feeding. That said, isoxazolines remain effective against many tick-borne diseases with longer transmission times and offer systemic protection against a range of parasites. The ideal strategy for dogs in high-risk areas may be a combination approach, though this should be discussed with a veterinarian, especially if there are cats in the household (permethrin is toxic to cats).
As for vaccination, no approved vaccine against E. canis currently exists. The obstacles are significant. The bacterium displays high genetic variability across different geographic regions, and it has evolved mechanisms to evade the immune system. Researchers have struggled to identify a single antigen that is both immunogenic enough to trigger lasting protection and conserved enough to work against diverse strains.22PubMed Central. Ehrlichia canis Vaccine Development: Challenges and Advances Additional challenges include figuring out how to stimulate the right type of immune response. Effective protection against an intracellular pathogen like E. canis requires strong cell-mediated immunity, not just antibodies, and early vaccine candidates have not been able to generate durable immunity.23PubMed Central. Progress and obstacles in vaccine development for the ehrlichioses For now, tick control remains the only reliable prevention strategy.
Geographic Spread and Emerging Risks
Ehrlichiosis has historically been concentrated in tropical and subtropical regions where the brown dog tick thrives. But the geographic range of the disease is expanding. Australia recorded its first incursion of canine monocytic ehrlichiosis in northern regions in 2020, a country that had previously been free of the disease.24Climate, ticks and disease. The emergence of tick-borne diseases in domestic animals in Australia In the United States, the tropical lineage of Rhipicephalus sanguineus, the tick most closely linked to ehrlichiosis transmission, is undergoing a northward range expansion, driven by climate trends and increased movement of dogs across regions.25PLoS ONE. Predicting the northward expansion of tropical lineage Rhipicephalus sanguineus sensu lato ticks in the United States and its implications for medical and veterinary health This means that veterinarians and dog owners in areas that previously considered ehrlichiosis uncommon may need to start testing for it routinely, particularly when dogs present with unexplained low platelets or fever after travel.
Can Humans Catch It From Their Dogs?
Dogs cannot directly transmit E. canis to people. The concern, rather, is that the same ticks feeding on an infected dog in the household could potentially bite a human. While humans are much more commonly affected by the closely related Ehrlichia chaffeensis, which causes human monocytotropic ehrlichiosis, there is growing evidence that E. canis itself may occasionally infect people. A review of the literature suggests that human infections with E. canis may be underestimated because the symptoms resemble those of E. chaffeensis infection, and standard laboratory tests often cannot distinguish between the two species.26PubMed Central. Ehrlichia canis: Is It a Pathogen for Humans and Other Primates? For dog owners, the practical message is that controlling ticks in your home and on your pets protects the whole household. Brown dog ticks are unusual among tick species in that they can complete their entire life cycle indoors, meaning a home infestation can build rapidly and persist without any outdoor exposure. If your dog has been diagnosed with ehrlichiosis, treating the indoor environment for ticks is as important as treating the dog itself.